Are You at Risk? Join Our Phase 3 Clinical Research Study on Early Signs of Alzheimer’s Disease
- Ariel Rieumont
- May 23, 2024
- 1 min read
Are you or someone you know experiencing early signs of Alzheimer’s disease? If you are between the ages of 55 and 90, you might qualify for our phase 3 clinical research study, which is now actively enrolling participants!
About the Study
Our research aims to better understand the early stages of Alzheimer’s disease and explore new potential treatments that could improve the quality of life for those affected. By participating in this study, you will be contributing to groundbreaking research that has the potential to make a significant impact in the field of Alzheimer’s care.
Who Can Participate?
We are looking for individuals who:
Are between 55 and 90 years old.
Are experiencing early signs of Alzheimer’s disease.
Meet other study-specific criteria (to be discussed during the screening process).
What to Expect
Participants will receive:
Comprehensive health assessments.
Access to cutting-edge medical care and monitoring throughout the study.
Potential access to new treatment options.
How to Get Involved
If you or someone you know fits the criteria and is interested in participating, please click the link below to learn more and sign up for the screening process. Your involvement could pave the way for new discoveries and treatments in Alzheimer’s disease.
Thank you for considering participation in our study. Together, we can make a difference in the fight against Alzheimer’s disease.
コメント